Clinical application for the preservation of phospho-proteins through in-situ tissue stabilization

C. Bart Rountree, Colleen A. Van Kirk, Hanning You, Wei Ding, Hien Dang, Heather D. VanGuilder, Willard M. Freeman

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Protein biomarkers will play a pivotal role in the future of personalized medicine for both diagnosis and treatment decision-making. While the results of several pre-clinical and small-scale clinical studies have demonstrated the value of protein biomarkers, there have been significant challenges to translating these findings into routine clinical care. Challenges to the use of protein biomarkers include inter-sample variability introduced by differences in post-collection handling and ex vivo degradation of proteins and protein modifications.Results: In this report, we re-create laboratory and clinical scenarios for sample collection and test the utility of a new tissue stabilization technique in preserving proteins and protein modifications. In the laboratory setting, tissue stabilization with the Denator Stabilizor T1 resulted in a significantly higher yield of phospho-protein when compared to standard snap freeze preservation. Furthermore, in a clinical scenario, tissue stabilization at collection resulted in a higher yield of total phospho-protein, total phospho-tyrosine, pErkT202/Y204 and pAktS473 when compared to standard methods. Tissue stabilization did not have a significant effect on other post-translational modifications such as acetylation and glycosylation, which are more stable ex-vivo. Tissue stabilization did decrease total RNA quantity and quality.Conclusion: Stabilization at the time of collection offers the potential to better preserve tissue protein and protein modification levels, as well as reduce the variability related to tissue processing delays that are often associated with clinical samples.

Original languageEnglish (US)
Article number61
JournalProteome Science
Volume8
DOIs
StatePublished - Nov 22 2010

Fingerprint

Stabilization
Tissue
Proteins
Biomarkers
Precision Medicine
Glycosylation
Acetylation
Post Translational Protein Processing
Proteolysis
Tyrosine
Decision Making
Medicine
RNA
Decision making
Degradation
Processing

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology

Cite this

Rountree, C. B., Van Kirk, C. A., You, H., Ding, W., Dang, H., VanGuilder, H. D., & Freeman, W. M. (2010). Clinical application for the preservation of phospho-proteins through in-situ tissue stabilization. Proteome Science, 8, [61]. https://doi.org/10.1186/1477-5956-8-61
Rountree, C. Bart ; Van Kirk, Colleen A. ; You, Hanning ; Ding, Wei ; Dang, Hien ; VanGuilder, Heather D. ; Freeman, Willard M. / Clinical application for the preservation of phospho-proteins through in-situ tissue stabilization. In: Proteome Science. 2010 ; Vol. 8.
@article{fde6ec02bd2c44afa5dcc5f4a6b7904a,
title = "Clinical application for the preservation of phospho-proteins through in-situ tissue stabilization",
abstract = "Protein biomarkers will play a pivotal role in the future of personalized medicine for both diagnosis and treatment decision-making. While the results of several pre-clinical and small-scale clinical studies have demonstrated the value of protein biomarkers, there have been significant challenges to translating these findings into routine clinical care. Challenges to the use of protein biomarkers include inter-sample variability introduced by differences in post-collection handling and ex vivo degradation of proteins and protein modifications.Results: In this report, we re-create laboratory and clinical scenarios for sample collection and test the utility of a new tissue stabilization technique in preserving proteins and protein modifications. In the laboratory setting, tissue stabilization with the Denator Stabilizor T1 resulted in a significantly higher yield of phospho-protein when compared to standard snap freeze preservation. Furthermore, in a clinical scenario, tissue stabilization at collection resulted in a higher yield of total phospho-protein, total phospho-tyrosine, pErkT202/Y204 and pAktS473 when compared to standard methods. Tissue stabilization did not have a significant effect on other post-translational modifications such as acetylation and glycosylation, which are more stable ex-vivo. Tissue stabilization did decrease total RNA quantity and quality.Conclusion: Stabilization at the time of collection offers the potential to better preserve tissue protein and protein modification levels, as well as reduce the variability related to tissue processing delays that are often associated with clinical samples.",
author = "Rountree, {C. Bart} and {Van Kirk}, {Colleen A.} and Hanning You and Wei Ding and Hien Dang and VanGuilder, {Heather D.} and Freeman, {Willard M.}",
year = "2010",
month = "11",
day = "22",
doi = "10.1186/1477-5956-8-61",
language = "English (US)",
volume = "8",
journal = "Proteome Science",
issn = "1477-5956",
publisher = "BioMed Central",

}

Clinical application for the preservation of phospho-proteins through in-situ tissue stabilization. / Rountree, C. Bart; Van Kirk, Colleen A.; You, Hanning; Ding, Wei; Dang, Hien; VanGuilder, Heather D.; Freeman, Willard M.

In: Proteome Science, Vol. 8, 61, 22.11.2010.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical application for the preservation of phospho-proteins through in-situ tissue stabilization

AU - Rountree, C. Bart

AU - Van Kirk, Colleen A.

AU - You, Hanning

AU - Ding, Wei

AU - Dang, Hien

AU - VanGuilder, Heather D.

AU - Freeman, Willard M.

PY - 2010/11/22

Y1 - 2010/11/22

N2 - Protein biomarkers will play a pivotal role in the future of personalized medicine for both diagnosis and treatment decision-making. While the results of several pre-clinical and small-scale clinical studies have demonstrated the value of protein biomarkers, there have been significant challenges to translating these findings into routine clinical care. Challenges to the use of protein biomarkers include inter-sample variability introduced by differences in post-collection handling and ex vivo degradation of proteins and protein modifications.Results: In this report, we re-create laboratory and clinical scenarios for sample collection and test the utility of a new tissue stabilization technique in preserving proteins and protein modifications. In the laboratory setting, tissue stabilization with the Denator Stabilizor T1 resulted in a significantly higher yield of phospho-protein when compared to standard snap freeze preservation. Furthermore, in a clinical scenario, tissue stabilization at collection resulted in a higher yield of total phospho-protein, total phospho-tyrosine, pErkT202/Y204 and pAktS473 when compared to standard methods. Tissue stabilization did not have a significant effect on other post-translational modifications such as acetylation and glycosylation, which are more stable ex-vivo. Tissue stabilization did decrease total RNA quantity and quality.Conclusion: Stabilization at the time of collection offers the potential to better preserve tissue protein and protein modification levels, as well as reduce the variability related to tissue processing delays that are often associated with clinical samples.

AB - Protein biomarkers will play a pivotal role in the future of personalized medicine for both diagnosis and treatment decision-making. While the results of several pre-clinical and small-scale clinical studies have demonstrated the value of protein biomarkers, there have been significant challenges to translating these findings into routine clinical care. Challenges to the use of protein biomarkers include inter-sample variability introduced by differences in post-collection handling and ex vivo degradation of proteins and protein modifications.Results: In this report, we re-create laboratory and clinical scenarios for sample collection and test the utility of a new tissue stabilization technique in preserving proteins and protein modifications. In the laboratory setting, tissue stabilization with the Denator Stabilizor T1 resulted in a significantly higher yield of phospho-protein when compared to standard snap freeze preservation. Furthermore, in a clinical scenario, tissue stabilization at collection resulted in a higher yield of total phospho-protein, total phospho-tyrosine, pErkT202/Y204 and pAktS473 when compared to standard methods. Tissue stabilization did not have a significant effect on other post-translational modifications such as acetylation and glycosylation, which are more stable ex-vivo. Tissue stabilization did decrease total RNA quantity and quality.Conclusion: Stabilization at the time of collection offers the potential to better preserve tissue protein and protein modification levels, as well as reduce the variability related to tissue processing delays that are often associated with clinical samples.

UR - http://www.scopus.com/inward/record.url?scp=78549284015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78549284015&partnerID=8YFLogxK

U2 - 10.1186/1477-5956-8-61

DO - 10.1186/1477-5956-8-61

M3 - Article

C2 - 21092202

AN - SCOPUS:78549284015

VL - 8

JO - Proteome Science

JF - Proteome Science

SN - 1477-5956

M1 - 61

ER -